Clinical Opal #7 - Ovarian cancer screening
Anna Li, a 46 year old high school teacher, presents to you for follow up after a recent metatarsal fracture. At the end of the visit, she asks you whether she can be screened for ovarian cancer.
She tells you that one of the other teachers at her school had just been diagnosed and she has become aware that 'there is a blood test that can pick it up early'. She has been very worried about it since her colleague was diagnosed.
Anna is fit and well and has no symptoms on further questioning. She has no family history of breast or ovarian cancer. Her last CST was 2 years ago and normal.
How would you respond to Anna's request?
A clinical practice guideline published in JAMA in 2018 stated that there is clear evidence that screening for ovarian cancer does not reduce ovarian cancer mortality.1 Furthermore, there is evidence that the harms from screening for ovarian cancer can be substantial, including unnecessary surgery for women who have false positive tests. They concluded that the harms of screening for ovarian cancer outweigh the benefit.
This is reflected in the RACGP Guidelines for Preventive Activities in General Practice (Red Book)2 and in the recommendations of Choosing Wisely Australia.3
Anna should therefore be informed that screening for ovarian cancer in asymptomatic, low-risk women like herself is not recommended due to the low sensitivity and specificity of available tests. This requires a sensitive and patient-centred discussion on the benefits and harms of screening.
References
Simon is a GP based in Newcastle, NSW, and a senior medical educator with Medcast. He also has medical education roles with the RACGP and GPSA.
Over the past three decades, Simon has worked in clinical and educational roles in NSW and the NT, as well as in the Republic of Ireland. He has published over 75 peer reviewed journal articles, and in 2018 received the RACGP Corliss award for his contribution to medical education.
Simon is passionate about high quality education and training. He has particular interests in GP supervisor professional development and the rational use of tests and medicines. He is a proud member of Doctors for the Environment. He spends his spare time drinking craft beer and pretending that he is a musician in the Euthymics, an all-GP band.
Become a member and get unlimited access to 100s of hours of premium education.
Learn more
Stories about topical steroid withdrawal are difficult to put into context for both consumers and health professionals. The outcome is that many consumers are avoiding using topical corticosteroids, which in many cases, makes it harder to manage conditions such as eczema.
You are working in ED and have received a call from Pathology regarding blood results that you took earlier on Lauren, who is 18 years old and 30 weeks pregnant with her first child. Discover the diagnosis behind Lauren's abnormal blood results and learn the symptoms, risks, and management of this life-threatening obstetric emergency.
Jaime has suffered from severe eczema for most of his life. This podcast delves into the interactions that take place between consumers and health professionals in the eczema journey.